# CSW Industrials, Inc.: financial statements, quarterly

CSW · NYSE · CIK 1624794 · [Materials](/sectors/materials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/csw.md) · [Financials](/companies/csw/financials.md) · [Filings](/companies/csw/filings.md) · [Insiders](/companies/csw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [175](/filings/0001624794-25-000012.md) | [211 d](/filings/0001624794-26-000027.md) | [226](/filings/0001624794-25-000080.md) | [228](/filings/0001624794-25-000103.md) | [194](/filings/0001624794-26-000014.md) | [231 d](/filings/0001624794-26-000027.md) | [264](/filings/0001624794-26-000046.md) | [277](/filings/0001624794-26-000057.md) | [233](/filings/0001624794-26-000014.md) | [309 d](/filings/0001624794-26-000027.md) | [351](/filings/0001624794-26-000046.md) | [361](/filings/0001624794-26-000057.md) |
| Cost of revenue | $m | [101](/filings/0001624794-25-000012.md) | [117 d](/filings/0001624794-26-000027.md) | [119](/filings/0001624794-25-000080.md) | [124](/filings/0001624794-25-000103.md) | [114](/filings/0001624794-26-000014.md) | [129 d](/filings/0001624794-26-000027.md) | [148](/filings/0001624794-26-000046.md) | [158](/filings/0001624794-26-000057.md) | [141](/filings/0001624794-26-000014.md) | [182 d](/filings/0001624794-26-000027.md) | [193](/filings/0001624794-26-000046.md) | [210](/filings/0001624794-26-000057.md) |
| Gross profit | $m | [74.0](/filings/0001624794-25-000012.md) | [93.6 d](/filings/0001624794-26-000027.md) | [107](/filings/0001624794-25-000080.md) | [104](/filings/0001624794-25-000103.md) | [80.1](/filings/0001624794-26-000014.md) | [102 d](/filings/0001624794-26-000027.md) | [115](/filings/0001624794-26-000046.md) | [119](/filings/0001624794-26-000057.md) | [92.4](/filings/0001624794-26-000014.md) | [127 d](/filings/0001624794-26-000027.md) | [157](/filings/0001624794-26-000046.md) | [152](/filings/0001624794-26-000057.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [46.4](/filings/0001624794-25-000012.md) | [47.8 d](/filings/0001624794-26-000027.md) | [52.4](/filings/0001624794-25-000080.md) | [52.4](/filings/0001624794-25-000103.md) | [50.5](/filings/0001624794-26-000014.md) | [56.8 d](/filings/0001624794-26-000027.md) | [60.6](/filings/0001624794-26-000046.md) | [62.4](/filings/0001624794-26-000057.md) | [75.1](/filings/0001624794-26-000014.md) | [71.4 d](/filings/0001624794-26-000027.md) | [77.5](/filings/0001624794-26-000046.md) | [76.4](/filings/0001624794-26-000057.md) |
| Operating income | $m | [27.6](/filings/0001624794-25-000012.md) | [44.3 d](/filings/0001624794-26-000027.md) | [55.1](/filings/0001624794-25-000080.md) | [51.5](/filings/0001624794-25-000103.md) | [29.6](/filings/0001624794-26-000014.md) | [45.0 d](/filings/0001624794-26-000027.md) | [54.9](/filings/0001624794-26-000046.md) | [56.8](/filings/0001624794-26-000057.md) | [17.3](/filings/0001624794-26-000014.md) | [39.5 d](/filings/0001624794-26-000027.md) | [79.9](/filings/0001624794-26-000046.md) | [75.5](/filings/0001624794-26-000057.md) |
| Income tax | $m | [7.1](/filings/0001624794-25-000012.md) | [10.0 d](/filings/0001624794-26-000027.md) | [14.0](/filings/0001624794-25-000080.md) | [12.9](/filings/0001624794-25-000103.md) | [4.3](/filings/0001624794-26-000014.md) | [11.5 d](/filings/0001624794-26-000027.md) | [13.2](/filings/0001624794-26-000046.md) | [14.7](/filings/0001624794-26-000057.md) | [(2.7)](/filings/0001624794-26-000014.md) | [7.5 d](/filings/0001624794-26-000027.md) | [17.1](/filings/0001624794-26-000046.md) | [15.2](/filings/0001624794-26-000057.md) |
| Net income | $m | [9.2](/filings/0001624794-25-000012.md) | [31.8 d](/filings/0001624794-26-000027.md) | [38.6](/filings/0001624794-26-000014.md) | [36.1](/filings/0001624794-26-000014.md) | [26.9](/filings/0001624794-26-000014.md) | [35.1 d](/filings/0001624794-26-000027.md) | [40.9](/filings/0001624794-26-000057.md) | [40.7](/filings/0001624794-26-000057.md) | [10.3](/filings/0001624794-26-000014.md) | [20.2 d](/filings/0001624794-26-000027.md) | [49.8](/filings/0001624794-26-000057.md) | [47.3](/filings/0001624794-26-000057.md) |
| Diluted EPS | $ per share | [0.59](/filings/0001624794-25-000012.md) | not reported | [2.47](/filings/0001624794-25-000080.md) | [2.26](/filings/0001624794-25-000103.md) | [1.60](/filings/0001624794-26-000014.md) | not reported | [2.43](/filings/0001624794-26-000046.md) | [2.41](/filings/0001624794-26-000057.md) | [0.62](/filings/0001624794-26-000014.md) | not reported | [3.04](/filings/0001624794-26-000046.md) | [2.90](/filings/0001624794-26-000057.md) |
| Basic EPS | $ per share | [0.59](/filings/0001624794-25-000012.md) | not reported | [2.48](/filings/0001624794-25-000080.md) | [2.27](/filings/0001624794-25-000103.md) | [1.60](/filings/0001624794-26-000014.md) | not reported | [2.43](/filings/0001624794-26-000046.md) | [2.42](/filings/0001624794-26-000057.md) | [0.62](/filings/0001624794-26-000014.md) | not reported | [3.05](/filings/0001624794-26-000046.md) | [2.91](/filings/0001624794-26-000057.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.0](/filings/0001624794-24-000007.md) | [22.2](/filings/0001624794-25-000056.md) | [18.9](/filings/0001624794-24-000058.md) | [273](/filings/0001624794-24-000091.md) | [214](/filings/0001624794-25-000012.md) | [226](/filings/0001624794-26-000027.md) | [38.0](/filings/0001624794-25-000080.md) | [31.5](/filings/0001624794-25-000103.md) | [40.2](/filings/0001624794-26-000014.md) | [33.8](/filings/0001624794-26-000057.md) | [47.5](/filings/0001624794-26-000046.md) | [37.2](/filings/0001624794-26-000057.md) |
| Current assets | $m | [308](/filings/0001624794-24-000007.md) | [331](/filings/0001624794-25-000056.md) | [331](/filings/0001624794-24-000058.md) | [609](/filings/0001624794-24-000091.md) | [563](/filings/0001624794-25-000012.md) | [593](/filings/0001624794-26-000027.md) | [451](/filings/0001624794-25-000080.md) | [448](/filings/0001624794-25-000103.md) | [535](/filings/0001624794-26-000014.md) | [589](/filings/0001624794-26-000057.md) | [616](/filings/0001624794-26-000046.md) | [615](/filings/0001624794-26-000057.md) |
| Total assets | $m | [993](/filings/0001624794-24-000007.md) | [1,043](/filings/0001624794-26-000027.md) | [1,051](/filings/0001624794-24-000058.md) | [1,359](/filings/0001624794-24-000091.md) | [1,350](/filings/0001624794-25-000012.md) | [1,379](/filings/0001624794-26-000027.md) | [1,536](/filings/0001624794-25-000080.md) | [1,518](/filings/0001624794-25-000103.md) | [2,286](/filings/0001624794-26-000014.md) | [2,317](/filings/0001624794-26-000057.md) | [2,334](/filings/0001624794-26-000046.md) | [2,329](/filings/0001624794-26-000057.md) |
| Current liabilities | $m | [111](/filings/0001624794-24-000007.md) | [116](/filings/0001624794-25-000056.md) | [121](/filings/0001624794-24-000058.md) | [159](/filings/0001624794-24-000091.md) | [135](/filings/0001624794-25-000012.md) | [147](/filings/0001624794-26-000027.md) | [158](/filings/0001624794-25-000080.md) | [162](/filings/0001624794-25-000103.md) | [226](/filings/0001624794-26-000014.md) | [227](/filings/0001624794-26-000057.md) | [228](/filings/0001624794-26-000046.md) | [261](/filings/0001624794-26-000057.md) |
| Total liabilities | $m | [385](/filings/0001624794-24-000007.md) | [408](/filings/0001624794-25-000056.md) | [381](/filings/0001624794-24-000058.md) | [309](/filings/0001624794-24-000091.md) | [286](/filings/0001624794-25-000012.md) | [287](/filings/0001624794-26-000027.md) | [406](/filings/0001624794-25-000080.md) | [369](/filings/0001624794-25-000103.md) | [1,199](/filings/0001624794-26-000014.md) | [1,247](/filings/0001624794-26-000057.md) | [1,241](/filings/0001624794-26-000046.md) | [1,192](/filings/0001624794-26-000057.md) |
| Long-term debt | $m | [153](/filings/0001624794-24-000007.md) | [166](/filings/0001624794-25-000056.md) | [115](/filings/0001624794-24-000058.md) | [0.0](/filings/0001624794-24-000091.md) | [0.0](/filings/0001624794-25-000012.md) | [0.0](/filings/0001624794-26-000027.md) | [95.0](/filings/0001624794-25-000080.md) | [60.0](/filings/0001624794-25-000103.md) | [768](/filings/0001624794-26-000014.md) | [840](/filings/0001624794-26-000057.md) | [826](/filings/0001624794-26-000046.md) | [735](/filings/0001624794-26-000057.md) |
| Current portion of debt | $m | [0.0](/filings/0001624794-24-000007.md) | [0.0](/filings/0001624794-25-000056.md) | [0.0](/filings/0001624794-24-000058.md) | [0.0](/filings/0001624794-24-000091.md) | [0.0](/filings/0001624794-25-000012.md) | [0.0](/filings/0001624794-26-000027.md) | not reported | not reported | [29.5](/filings/0001624794-26-000014.md) | [29.5](/filings/0001624794-26-000057.md) | [29.5](/filings/0001624794-26-000046.md) | [29.5](/filings/0001624794-26-000057.md) |
| Shareholders' equity | $m | [589](/filings/0001624794-25-000012.md) | [616](/filings/0001624794-26-000027.md) | [650](/filings/0001624794-26-000014.md) | [1,030](/filings/0001624794-26-000014.md) | [1,044](/filings/0001624794-26-000014.md) | [1,072](/filings/0001624794-26-000057.md) | [1,110](/filings/0001624794-26-000057.md) | [1,130](/filings/0001624794-26-000057.md) | [1,067](/filings/0001624794-26-000014.md) | [1,050](/filings/0001624794-26-000057.md) | [1,074](/filings/0001624794-26-000057.md) | [1,117](/filings/0001624794-26-000057.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.0 d](/filings/0001624794-25-000012.md) | [22.4 d](/filings/0001624794-26-000027.md) | [62.7](/filings/0001624794-25-000080.md) | [67.5 d](/filings/0001624794-25-000103.md) | [10.9 d](/filings/0001624794-26-000014.md) | [27.3 d](/filings/0001624794-26-000027.md) | [60.6](/filings/0001624794-26-000046.md) | [61.8 d](/filings/0001624794-26-000057.md) | [28.9 d](/filings/0001624794-26-000014.md) | [(1.7) d](/filings/0001624794-26-000027.md) | [75.6](/filings/0001624794-26-000046.md) | [95.4 d](/filings/0001624794-26-000057.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001624794-25-000012.md) | [4.9 d](/filings/0001624794-26-000027.md) | [3.1](/filings/0001624794-25-000080.md) | [5.5 d](/filings/0001624794-25-000103.md) | [3.1 d](/filings/0001624794-26-000014.md) | [4.5 d](/filings/0001624794-26-000027.md) | [2.9](/filings/0001624794-26-000046.md) | [3.1 d](/filings/0001624794-26-000057.md) | [6.1 d](/filings/0001624794-26-000014.md) | [5.1 d](/filings/0001624794-26-000027.md) | [6.0](/filings/0001624794-26-000046.md) | [3.5 d](/filings/0001624794-26-000057.md) |
| Dividends paid | $m | [3.0 d](/filings/0001624794-25-000012.md) | [3.0 d](/filings/0001624794-26-000027.md) | [3.3](/filings/0001624794-25-000080.md) | [3.3](/filings/0001624794-25-000103.md) | [4.0](/filings/0001624794-26-000014.md) | [4.0 d](/filings/0001624794-26-000027.md) | [4.5](/filings/0001624794-26-000046.md) | [4.5](/filings/0001624794-25-000103.md) | [4.5](/filings/0001624794-26-000014.md) | [4.4 d](/filings/0001624794-26-000027.md) | [4.9](/filings/0001624794-26-000046.md) | [4.9 d](/filings/0001624794-26-000057.md) |
| Share repurchases | $m | [6.7 d](/filings/0001624794-25-000012.md) | [4.6 d](/filings/0001624794-26-000027.md) | [7.9](/filings/0001624794-25-000080.md) | [4.4 d](/filings/0001624794-25-000103.md) | [8.6 d](/filings/0001624794-26-000014.md) | [6.8 d](/filings/0001624794-26-000027.md) | [9.1](/filings/0001624794-26-000046.md) | [17.0 d](/filings/0001624794-26-000057.md) | [72.7 d](/filings/0001624794-26-000014.md) | [34.0 d](/filings/0001624794-26-000027.md) | [36.3](/filings/0001624794-26-000046.md) | [5.8 d](/filings/0001624794-26-000057.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.5](/filings/0001624794-24-000007.md) | [15.5](/filings/0001624794-24-000058.md) | [15.6](/filings/0001624794-24-000091.md) | [15.6](/filings/0001624794-25-000012.md) | [15.6](/filings/0001624794-25-000080.md) | [15.9](/filings/0001624794-25-000103.md) | [16.9](/filings/0001624794-26-000014.md) | [16.9](/filings/0001624794-26-000046.md) | [16.8](/filings/0001624794-26-000057.md) | [16.6](/filings/0001624794-26-000014.md) | [16.4](/filings/0001624794-26-000046.md) | [16.3](/filings/0001624794-26-000057.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,292,144 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001624794-26-000057.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 06:58 ET. No prices; not investment advice.